HSE have published their latest bulletins:
REACH
- Information on evaluation activity in 2023 (Article 54 reporting)
HSE has an obligation to report annually on the activity undertaken to evaluate registration dossiers and substances.
This is described in Article 54 of UK REACH. The Article 54 report for 2023 can be found on HSE’s website. The report also directs registrants to the recommendations to registrants which aim to improve the quality of future registrations.
Biocides
- Upcoming GB active substance dossier submission deadline
Take action to keep your active substance in the GB Review Programme
The active substance/product type combinations listed below have been successfully notified into the GB Review Programme following an open invitation. The next step is for a full active substance dossier to be submitted to HSE by the following deadline:
- Chrysanthemum cinerariaefolium, extract from open and mature flowers of Tanacetum cinerariifolium obtained with hydrocarbon solvents (Redefined from Pyrethrins and Pyrethroids and Chrysanthemum cinerariaefolium, ext.) (CAS 89997-63-7 EC 289-699-3) in product types 18 and 19 (deadline: 23 May 2025)
Only the person, company or task force/consortium that successfully notified the active substance/product type combinations listed above can submit a dossier. If any of these active substance/product type combinations are important to you, consider contacting the notifier to let them know. You may even be able to join them in supporting the active substance.
Check the list of successful notifiers
If a dossier is not submitted by the deadline, these active substance/product type combinations will be subject to a GB non-approval decision. This means the active substance will no longer be able to be used in biocidal products of the relevant product types in GB. In addition articles treated with such products will no longer be able to be placed on the market in GB. HSE will provide separate updates on these where relevant.
- Upcoming GB active substance renewal submission deadline
Apply for active substance renewal by the deadline to keep products on the GB market
Under the GB BPR, active substance approvals will expire unless a renewal application is submitted at least 550 days before their expiry date.
The 550-day deadline is coming up for the following active substance/product type combination under GB BPR:
- Bacillus thuringiensis subsp. kurstaki, strain ABTS-351 (CAS n/a EC n/a) in product type 18 (deadline: 27 August 2025)
Any person, company or task force/consortium can support an active substance/product type combination for renewal – it doesn’t have to be the original supporter.
Check the GB Article 95 List to see who the original supporters were
If this active substance/product type combination is important to you, consider contacting your supplier to let them know. If a renewal application is not submitted for the above active substance/product type combination under GB BPR, the approval will expire. This means the active substance will no longer be able to be used in biocidal products of the relevant product type in GB. In addition articles treated with such products will no longer be able to be placed on the market in GB.
